Journal of General Internal Medicine

, Volume 14, Issue 7, pp 446–448

When should we delay highly active antiretroviral therapy?


  • David R. Bangsberg
    • Epidemiology and Prevention Intervention CenterSan Francisco General Hospital
  • Andrew Moss
    • Department of Epidemiology and BiostatisticsUniversity of California

DOI: 10.1046/j.1525-1497.1999.05109.x

Cite this article as:
Bangsberg, D.R. & Moss, A. J GEN INTERN MED (1999) 14: 446. doi:10.1046/j.1525-1497.1999.05109.x

Copyright information

© Society of General Internal Medicine 1999